The Anthos Therapeutics acquisition represents a homecoming for its drug abelacimab, which originated in Novartis’s labs. The antibody offers the potential to prevent...
ByglobalreutersFebruary 11, 2025This page displays an interactive map of the current status of state decisions on the Affordable Care Act's Medicaid expansion. Additional Medicaid expansion...
ByglobalreutersFebruary 11, 2025By MIKE MAGEE “As machines become more intelligent and can performance more sophisticated functions, a new relationship between human and automation is dawning....
ByglobalreutersFebruary 11, 2025A data safety monitoring board recommended pausing the Phase 2b test of Pliant’s bexotegrast, an experimental treatment for idiopathic pulmonary fibrosis. The move...
ByglobalreutersFebruary 10, 2025How do you market healthcare when there is limited physician access—and the focus is on managing care, not increasing patient volume? Health systems...
ByglobalreutersFebruary 10, 2025By MATTHEW HOLT There’s been a lot of discussion lately about whether digital health is a legitimate place for venture capital. There have...
ByglobalreutersFebruary 10, 2025Health coverage enrollment through the Affordable Care Act (ACA) marketplaces now exceeds 24 million people, a dramatic increase in recent years fueled largely...
ByglobalreutersFebruary 10, 2025Concussions can have serious consequences. Learn how to prevent, recognize, and recover from sports-related concussions to stay safe and perform at your best.
ByglobalreutersFebruary 10, 2025Sionna Therapeutics found strong investor interest in its cystic fibrosis drugs, which could rival blockbuster Vertex Pharmaceuticals product Trikafta. The biotech has three...
ByglobalreutersFebruary 9, 2025Paths forward for accountable care. Value of continuity in primary care. CDC morale falling. What happened to big work comp PPOs? Homage to...
ByglobalreutersFebruary 8, 2025